CN Stock MarketDetailed Quotes

600276 Jiangsu Hengrui Pharmaceuticals

Watchlist
  • 45.61
  • +1.31+2.96%
Trading Apr 26 14:44 CST
290.95BMarket Cap65.63P/E (TTM)

Jiangsu Hengrui Pharmaceuticals Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
9.20%6B
7.26%22.82B
6.70%17.01B
9.19%11.17B
0.25%5.49B
-17.87%21.28B
-21.06%15.95B
-23.08%10.23B
-20.93%5.48B
-6.59%25.91B
Operating revenue
9.20%6B
7.26%22.82B
6.70%17.01B
9.19%11.17B
0.25%5.49B
-17.87%21.28B
-21.06%15.95B
-23.08%10.23B
-20.93%5.48B
-6.59%25.91B
Other operating revenue
----
611.05%442.6M
----
6,559.70%124.6M
----
-50.29%62.25M
----
-94.61%1.87M
----
2.72%125.22M
Total operating cost
4.91%4.41B
2.63%18.21B
5.49%13.26B
9.27%8.73B
1.18%4.21B
-18.57%17.75B
-17.95%12.57B
-21.40%7.99B
-19.46%4.16B
2.40%21.79B
Operating cost
9.70%942.85M
1.11%3.53B
-0.42%2.66B
4.83%1.77B
0.49%859.52M
-6.82%3.49B
-2.19%2.67B
-3.78%1.69B
-6.05%855.29M
11.74%3.74B
Operating tax surcharges
13.86%58.02M
15.16%219.26M
13.07%162.73M
17.68%109.61M
0.68%50.95M
-5.66%190.39M
-8.27%143.92M
-12.02%93.14M
-12.06%50.61M
-21.46%201.81M
Operating expense
5.66%1.76B
3.12%7.58B
4.78%5.41B
12.61%3.68B
-5.05%1.67B
-21.70%7.35B
-26.22%5.16B
-29.98%3.27B
-24.53%1.76B
-4.27%9.38B
Administration expense
5.61%576.3M
4.79%2.42B
14.14%1.68B
10.98%1.08B
-2.43%545.67M
-19.36%2.31B
-4.57%1.47B
-16.09%976.71M
-11.09%559.29M
-6.73%2.86B
Financial expense
-117.50%-148.64M
-1.60%-478.39M
-0.12%-371.46M
-10.47%-243.82M
7.35%-68.34M
-39.33%-470.87M
-52.72%-371.03M
-106.76%-220.7M
10.08%-73.76M
-85.95%-337.96M
-Interest expense (Financial expense)
----
-9.06%5.9M
130.68%4.74M
52.73%3.69M
-26.71%985.81K
37.82%6.49M
--2.06M
135.50%2.41M
--1.35M
--4.71M
-Interest Income (Financial expense)
-98.55%-166.46M
-23.84%-477.14M
-41.10%-350.86M
-24.25%-208.35M
9.48%-83.84M
-4.85%-385.28M
13.39%-248.67M
10.71%-167.69M
4.81%-92.62M
-26.59%-367.46M
Research and development
6.21%1.22B
1.38%4.95B
6.52%3.73B
6.73%2.33B
14.05%1.15B
-17.78%4.89B
-15.56%3.5B
-15.36%2.18B
-23.47%1.01B
19.13%5.94B
Credit Impairment Loss
-486.75%-12.98M
165.65%17.25M
82.97%-3.07M
141.12%16.29M
121.54%3.36M
-749.71%-26.28M
32.89%-18.04M
-12.90%-39.61M
40.17%-15.58M
160.42%4.05M
Asset Impairment Loss
--109.56K
26.91%-107.22M
---12.71M
----
----
-958.25%-146.68M
----
----
--1.25K
-90.44%-13.86M
Other net revenue
-12.17%51.39M
-47.88%304.27M
-32.36%186.48M
-17.62%130.64M
31.86%58.51M
5.71%583.77M
42.90%275.7M
71.44%158.58M
35.27%44.38M
-0.41%552.26M
Fair value change income
293.79%7.34M
-176.15%-58.26M
-2,111.84%-35.77M
-271.47%-27.62M
63.13%-3.79M
111.14%76.5M
96.46%-1.62M
254.47%16.11M
-763.20%-10.27M
119.63%36.23M
Invest income
-98.14%615.9K
-112.69%-49.16M
-110.77%-11.57M
-117.08%-9.56M
12.32%33.1M
81.49%387.36M
-36.09%107.41M
-45.20%55.98M
-41.54%29.47M
-37.49%213.43M
-Including: Investment income associates
----
-15.40%-72.7M
---47.11M
---41.8M
----
-807.71%-63M
----
----
----
---6.94M
Asset deal income
26.53%1.62M
-42.22%3.16M
1,956.49%4.53M
665.72%2.61M
161.38%1.28M
62.36%5.47M
-92.81%220.44K
-120.18%-460.98K
-9.28%490.46K
13.00%3.37M
Other revenue
122.67%54.68M
73.45%498.49M
30.54%245.07M
17.67%148.92M
-39.00%24.56M
-7.00%287.4M
99.03%187.73M
276.79%126.56M
343.70%40.26M
48.87%309.04M
Operating profit
21.69%1.64B
19.41%4.91B
7.93%3.94B
7.15%2.57B
-1.56%1.34B
-11.85%4.11B
-28.02%3.65B
-25.67%2.4B
-24.15%1.37B
-33.43%4.66B
Add:Non operating Income
-53.56%198.81K
82.46%3.8M
73.51%2.43M
70.07%1.61M
17.45%428.07K
-6.35%2.08M
-54.21%1.4M
-39.84%948.61K
-68.30%364.48K
107.94%2.22M
Less:Non operating expense
564.84%133.7M
69.42%246.59M
10.18%131.39M
24.45%59.38M
2,876.16%20.11M
-27.49%145.55M
-19.04%119.24M
-52.78%47.71M
-97.66%675.69K
78.17%200.73M
Total profit
13.42%1.5B
17.60%4.67B
7.88%3.81B
6.83%2.51B
-2.98%1.32B
-11.15%3.97B
-28.30%3.53B
-24.80%2.35B
-22.98%1.37B
-35.23%4.47B
Less:Income tax cost
47.80%135.02M
153.86%389.29M
-17.49%361.35M
-21.76%222.04M
-41.86%91.36M
965.50%153.35M
-40.57%437.95M
-39.00%283.8M
-43.21%157.14M
-103.02%-17.72M
Net profit
10.87%1.37B
12.13%4.28B
11.47%3.45B
10.75%2.29B
2.08%1.23B
-14.92%3.82B
-26.14%3.1B
-22.32%2.07B
-19.24%1.21B
-28.93%4.48B
Net profit from continuing operation
10.87%1.37B
12.13%4.28B
11.47%3.45B
10.75%2.29B
2.08%1.23B
-14.92%3.82B
-26.14%3.1B
-22.32%2.07B
-19.24%1.21B
-28.93%4.48B
Less:Minority Profit
74.79%-1.44M
73.02%-24.62M
70.59%-22.75M
65.17%-17.86M
80.07%-5.72M
-97.51%-91.23M
-405.50%-77.34M
-886.91%-51.27M
-5,499.91%-28.68M
-137.00%-46.19M
Net profit of parent company owners
10.48%1.37B
10.14%4.3B
9.47%3.47B
8.91%2.31B
0.17%1.24B
-13.77%3.91B
-24.57%3.17B
-20.55%2.12B
-17.35%1.24B
-28.41%4.53B
Earning per share
Basic earning per share
10.53%0.21
11.48%0.68
10.00%0.55
9.09%0.36
0.00%0.19
-14.08%0.61
-24.24%0.5
-21.43%0.33
-17.39%0.19
-28.28%0.71
Diluted earning per share
10.53%0.21
11.48%0.68
10.00%0.55
9.09%0.36
0.00%0.19
-14.08%0.61
-24.24%0.5
-21.43%0.33
-17.39%0.19
-28.28%0.71
Other composite income
69.90%-5.93M
12.43%17.84M
311.21%14M
659.72%22.51M
-14,648.05%-19.69M
302.41%15.87M
-672.97%-6.63M
-1,273.58%-4.02M
-104.73%-133.48K
33.02%-7.84M
Other composite income of parent company owners
66.49%-6.14M
8.96%16.09M
246.37%10.92M
505.91%18.74M
-72,524.52%-18.33M
300.53%14.77M
-948.39%-7.46M
-12,147.55%-4.62M
-101.00%-25.24K
34.95%-7.37M
Other composite income of minority owners
115.94%216.54K
59.17%1.75M
272.75%3.09M
532.90%3.77M
-1,155.38%-1.36M
331.60%1.1M
665.88%828.16K
333.43%595.53K
-135.26%-108.25K
-24.50%-473.97K
Total composite income
12.18%1.36B
12.13%4.3B
12.16%3.47B
12.06%2.31B
0.46%1.21B
-14.41%3.83B
-26.29%3.09B
-22.47%2.06B
-19.40%1.21B
-28.92%4.48B
Total composite income of parent company owners
11.63%1.36B
10.13%4.32B
10.07%3.48B
10.04%2.33B
-1.31%1.22B
-13.30%3.92B
-24.74%3.17B
-20.72%2.11B
-17.49%1.24B
-28.40%4.52B
Total composite income of minority owners
82.70%-1.22M
74.63%-22.87M
74.30%-19.66M
72.20%-14.09M
75.43%-7.07M
-93.16%-90.14M
-395.35%-76.52M
-829.79%-50.68M
-13,932.72%-28.79M
-134.84%-46.66M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Suya Jincheng Certified Public Accountants (Special General Partnership)
--
--
--
Suya Jincheng Certified Public Accountants (Special General Partnership)
--
--
--
Suya Jincheng Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 9.20%6B7.26%22.82B6.70%17.01B9.19%11.17B0.25%5.49B-17.87%21.28B-21.06%15.95B-23.08%10.23B-20.93%5.48B-6.59%25.91B
Operating revenue 9.20%6B7.26%22.82B6.70%17.01B9.19%11.17B0.25%5.49B-17.87%21.28B-21.06%15.95B-23.08%10.23B-20.93%5.48B-6.59%25.91B
Other operating revenue ----611.05%442.6M----6,559.70%124.6M-----50.29%62.25M-----94.61%1.87M----2.72%125.22M
Total operating cost 4.91%4.41B2.63%18.21B5.49%13.26B9.27%8.73B1.18%4.21B-18.57%17.75B-17.95%12.57B-21.40%7.99B-19.46%4.16B2.40%21.79B
Operating cost 9.70%942.85M1.11%3.53B-0.42%2.66B4.83%1.77B0.49%859.52M-6.82%3.49B-2.19%2.67B-3.78%1.69B-6.05%855.29M11.74%3.74B
Operating tax surcharges 13.86%58.02M15.16%219.26M13.07%162.73M17.68%109.61M0.68%50.95M-5.66%190.39M-8.27%143.92M-12.02%93.14M-12.06%50.61M-21.46%201.81M
Operating expense 5.66%1.76B3.12%7.58B4.78%5.41B12.61%3.68B-5.05%1.67B-21.70%7.35B-26.22%5.16B-29.98%3.27B-24.53%1.76B-4.27%9.38B
Administration expense 5.61%576.3M4.79%2.42B14.14%1.68B10.98%1.08B-2.43%545.67M-19.36%2.31B-4.57%1.47B-16.09%976.71M-11.09%559.29M-6.73%2.86B
Financial expense -117.50%-148.64M-1.60%-478.39M-0.12%-371.46M-10.47%-243.82M7.35%-68.34M-39.33%-470.87M-52.72%-371.03M-106.76%-220.7M10.08%-73.76M-85.95%-337.96M
-Interest expense (Financial expense) -----9.06%5.9M130.68%4.74M52.73%3.69M-26.71%985.81K37.82%6.49M--2.06M135.50%2.41M--1.35M--4.71M
-Interest Income (Financial expense) -98.55%-166.46M-23.84%-477.14M-41.10%-350.86M-24.25%-208.35M9.48%-83.84M-4.85%-385.28M13.39%-248.67M10.71%-167.69M4.81%-92.62M-26.59%-367.46M
Research and development 6.21%1.22B1.38%4.95B6.52%3.73B6.73%2.33B14.05%1.15B-17.78%4.89B-15.56%3.5B-15.36%2.18B-23.47%1.01B19.13%5.94B
Credit Impairment Loss -486.75%-12.98M165.65%17.25M82.97%-3.07M141.12%16.29M121.54%3.36M-749.71%-26.28M32.89%-18.04M-12.90%-39.61M40.17%-15.58M160.42%4.05M
Asset Impairment Loss --109.56K26.91%-107.22M---12.71M---------958.25%-146.68M----------1.25K-90.44%-13.86M
Other net revenue -12.17%51.39M-47.88%304.27M-32.36%186.48M-17.62%130.64M31.86%58.51M5.71%583.77M42.90%275.7M71.44%158.58M35.27%44.38M-0.41%552.26M
Fair value change income 293.79%7.34M-176.15%-58.26M-2,111.84%-35.77M-271.47%-27.62M63.13%-3.79M111.14%76.5M96.46%-1.62M254.47%16.11M-763.20%-10.27M119.63%36.23M
Invest income -98.14%615.9K-112.69%-49.16M-110.77%-11.57M-117.08%-9.56M12.32%33.1M81.49%387.36M-36.09%107.41M-45.20%55.98M-41.54%29.47M-37.49%213.43M
-Including: Investment income associates -----15.40%-72.7M---47.11M---41.8M-----807.71%-63M---------------6.94M
Asset deal income 26.53%1.62M-42.22%3.16M1,956.49%4.53M665.72%2.61M161.38%1.28M62.36%5.47M-92.81%220.44K-120.18%-460.98K-9.28%490.46K13.00%3.37M
Other revenue 122.67%54.68M73.45%498.49M30.54%245.07M17.67%148.92M-39.00%24.56M-7.00%287.4M99.03%187.73M276.79%126.56M343.70%40.26M48.87%309.04M
Operating profit 21.69%1.64B19.41%4.91B7.93%3.94B7.15%2.57B-1.56%1.34B-11.85%4.11B-28.02%3.65B-25.67%2.4B-24.15%1.37B-33.43%4.66B
Add:Non operating Income -53.56%198.81K82.46%3.8M73.51%2.43M70.07%1.61M17.45%428.07K-6.35%2.08M-54.21%1.4M-39.84%948.61K-68.30%364.48K107.94%2.22M
Less:Non operating expense 564.84%133.7M69.42%246.59M10.18%131.39M24.45%59.38M2,876.16%20.11M-27.49%145.55M-19.04%119.24M-52.78%47.71M-97.66%675.69K78.17%200.73M
Total profit 13.42%1.5B17.60%4.67B7.88%3.81B6.83%2.51B-2.98%1.32B-11.15%3.97B-28.30%3.53B-24.80%2.35B-22.98%1.37B-35.23%4.47B
Less:Income tax cost 47.80%135.02M153.86%389.29M-17.49%361.35M-21.76%222.04M-41.86%91.36M965.50%153.35M-40.57%437.95M-39.00%283.8M-43.21%157.14M-103.02%-17.72M
Net profit 10.87%1.37B12.13%4.28B11.47%3.45B10.75%2.29B2.08%1.23B-14.92%3.82B-26.14%3.1B-22.32%2.07B-19.24%1.21B-28.93%4.48B
Net profit from continuing operation 10.87%1.37B12.13%4.28B11.47%3.45B10.75%2.29B2.08%1.23B-14.92%3.82B-26.14%3.1B-22.32%2.07B-19.24%1.21B-28.93%4.48B
Less:Minority Profit 74.79%-1.44M73.02%-24.62M70.59%-22.75M65.17%-17.86M80.07%-5.72M-97.51%-91.23M-405.50%-77.34M-886.91%-51.27M-5,499.91%-28.68M-137.00%-46.19M
Net profit of parent company owners 10.48%1.37B10.14%4.3B9.47%3.47B8.91%2.31B0.17%1.24B-13.77%3.91B-24.57%3.17B-20.55%2.12B-17.35%1.24B-28.41%4.53B
Earning per share
Basic earning per share 10.53%0.2111.48%0.6810.00%0.559.09%0.360.00%0.19-14.08%0.61-24.24%0.5-21.43%0.33-17.39%0.19-28.28%0.71
Diluted earning per share 10.53%0.2111.48%0.6810.00%0.559.09%0.360.00%0.19-14.08%0.61-24.24%0.5-21.43%0.33-17.39%0.19-28.28%0.71
Other composite income 69.90%-5.93M12.43%17.84M311.21%14M659.72%22.51M-14,648.05%-19.69M302.41%15.87M-672.97%-6.63M-1,273.58%-4.02M-104.73%-133.48K33.02%-7.84M
Other composite income of parent company owners 66.49%-6.14M8.96%16.09M246.37%10.92M505.91%18.74M-72,524.52%-18.33M300.53%14.77M-948.39%-7.46M-12,147.55%-4.62M-101.00%-25.24K34.95%-7.37M
Other composite income of minority owners 115.94%216.54K59.17%1.75M272.75%3.09M532.90%3.77M-1,155.38%-1.36M331.60%1.1M665.88%828.16K333.43%595.53K-135.26%-108.25K-24.50%-473.97K
Total composite income 12.18%1.36B12.13%4.3B12.16%3.47B12.06%2.31B0.46%1.21B-14.41%3.83B-26.29%3.09B-22.47%2.06B-19.40%1.21B-28.92%4.48B
Total composite income of parent company owners 11.63%1.36B10.13%4.32B10.07%3.48B10.04%2.33B-1.31%1.22B-13.30%3.92B-24.74%3.17B-20.72%2.11B-17.49%1.24B-28.40%4.52B
Total composite income of minority owners 82.70%-1.22M74.63%-22.87M74.30%-19.66M72.20%-14.09M75.43%-7.07M-93.16%-90.14M-395.35%-76.52M-829.79%-50.68M-13,932.72%-28.79M-134.84%-46.66M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Suya Jincheng Certified Public Accountants (Special General Partnership)------Suya Jincheng Certified Public Accountants (Special General Partnership)------Suya Jincheng Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg